IKT - Inhibikase Therapeutics, Inc.

QQQ $ 452.83 $ 6.97 (1.56 %)

DIA $ 399.31 $ 3.70 (0.94 %)

SPY $ 529.09 $ 6.48 (1.24 %)

TLT $ 92.14 $ 1.24 (1.36 %)

GLD $ 220.89 $ 2.80 (1.28 %)

Previous Close

$ 1.99

Open

$ 1.74

Bid

$ 0.00 x 0

Ask

$ 0.00 x 0

Day's Range

$ 1.74 - $ 2.08

52 Week Range

$ 0.79 - $ 4.35

Volume

564,392

Average Volume

Market Cap

12.62M

Beta (5Y Monthly)

$ 0.97

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	05-15-2024	03-31-2024	10-Q
2	03-27-2024	12-31-2023	10-K
3	11-14-2023	09-30-2023	10-Q
4	08-14-2023	06-30-2023	10-Q
5	05-15-2023	03-31-2023	10-Q
6	03-31-2023	12-31-2022	10-K
7	11-14-2022	09-30-2022	10-Q
8	08-12-2022	06-30-2022	10-Q
9	05-16-2022	03-31-2022	10-Q
10	03-31-2022	12-31-2021	10-K
11	11-15-2021	09-30-2021	10-Q
12	08-16-2021	06-30-2021	10-Q
13	05-17-2021	03-31-2021	10-Q
14	03-31-2021	12-31-2020	10-K

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Inhibikase Therapeutics Q1 2024 GAAP EPS $...
05/16/2024 07:06:46

Inhibikase Therapeutics (NASDAQ:IKT) reported quarterly losses of $(0.73) per share which beat the analyst consensus estimate o...

Inhibikase Therapeutics Announces Request ...
05/15/2024 13:13:34

Inhibikase Therapeutics, Inc. (NASDAQ:IKT) ("Inhibikase" or "Company"), a clinical-stage pharmaceutical company...

Inhibikase Therapeutics Announces Final Pr...
05/09/2024 12:52:14

- FDA indicated IkT-001Pro can be considered a New Molecular Entity and is eligible for exclusivity designations in Pulmonary A...

why-vaxxinity-shares-are-trading-lower-by-around-55-here-are-other-stocks-moving-in-mondays-mid-day-session

Why Vaxxinity Shares Are Trading Lower By ...
04/22/2024 17:26:48

12-health-care-stocks-moving-in-mondays-intraday-session

12 Health Care Stocks Moving In Monday's I...
04/22/2024 16:31:48

Inhibikase Therapeutics Issues Letter To S...
04/18/2024 20:37:32

Inhibikase Therapeutics, Inc. (NASDAQ:IKT) (Inhibikase or Company), a clinical-stage pharmaceutical company developing protein ...

Inhibikase Therapeutics Announces Apr. 5 P...
04/03/2024 12:07:57

Inhibikase Therapeutics Q4 EPS $(0.64) Bea...
03/28/2024 03:45:50

Inhibikase Therapeutics (NASDAQ:IKT) reported quarterly losses of $(0.64) per share which beat the analyst consensus estimate o...

Inhibikase Therapeutics FY23 EPS $(3.57); ...
03/27/2024 20:38:40

HC Wainwright & Co. Reiterates Buy on Inhi...
03/07/2024 16:26:19

HC Wainwright & Co. analyst Edward White reiterates Inhibikase Therapeutics (NASDAQ:IKT) with a Buy and maintains $27 pr...

Inhibikase Therapeutics To Provide Trial U...
03/07/2024 13:37:27

Inhibikase Therapeutics, Inc. (NASDAQ:IKT) ("Inhibikase" or "Company"), a clinical-stage pharmaceutical company...

HC Wainwright & Co. Maintains Buy Rating f...
03/05/2024 17:00:30

HC Wainwright & Co. Maintains Buy on Inhib...
03/05/2024 15:50:51

HC Wainwright & Co. analyst Edward White maintains Inhibikase Therapeutics (NASDAQ:IKT) with a Buy and maintains $27 pri...

Inhibikase Therapeutics Announces Full Out...
02/28/2024 21:51:57

Inhibikase Therapeutics, Inc. (NASDAQ:IKT) ("Inhibikase" or "Company"), a clinical-stage pharmaceutical company...

Inhibikase Reports Preliminary Outcomes Of...
02/07/2024 12:57:50

Inhibikase Therapeutics Announces Publicat...
01/29/2024 14:06:34

12-health-care-stocks-moving-in-fridays-intraday-session

12 Health Care Stocks Moving In Friday's I...
01/26/2024 17:31:09

12-health-care-stocks-moving-in-thursdays-intraday-session

12 Health Care Stocks Moving In Thursday's...
01/25/2024 17:31:07

12-health-care-stocks-moving-in-wednesdays-intraday-session

12 Health Care Stocks Moving In Wednesday'...
01/24/2024 17:31:02

Inhibikase Therapeutics Appoints Garth Lee...
01/16/2024 21:12:04